title: [Effects of suplatast tosilate on airway inflammation and interleukin-5 in asthmatic rats].
abstract: OBJECTIVE
  To study the effects of suplatast tosilate (IPD) on the airway inflammation and expression of interleukin-5 in asthmatic rats.
  
  
  METHODS
  Fifty adult male Sprague-Dawley rats (4-week- old) were randomly assigned to five groups: placebo control, untreated asthma, budesonide(BUD)-treated asthma , early or late IPD intervention group (n=10 rats each). Asthmatic mode was prepared by ovalbumin sensitizion and challenge. Inflammatory cells and the percentage of EOS were detected in bronchoalveolar lavage fluid (BALF). The lung tissues were removed to detect the lung histomorphology. Gene expression of IL-5 was measured by reverse transcription-polymerase chain reaction (RT-PCR). Levels of interleukin 5 (IL-5) in BALF were measured using ELISA.
  
  
  RESULTS
  The inflammatory cells and the percentage of EOS in BALF, IL-5 levels in BALF and IL-5 mRNA expression in the lung tissues were obviously higher in the untreated asthma group than the control group (P<0.05), while the parameters in the IPD or BUD-treated asthma groups were significantly lower than the untreated asthma group (P<0.05).
  
  
  CONCLUSIONS
  IPD treatment can alleviate airway inflammation in asthmatic rats, possibly through inhibiting IL-5 mRNA transcripts.
authors.affiliation: Department of Pediatrics, Hunan People's Hospital, Changcha 410005, China. ligunpd@163.com.
authors.forename: Dan
authors.initials: D
authors.lastname: Liu
authors.forename: Yun
authors.initials: Y
authors.lastname: Li
authors.forename: Li-Li
authors.initials: LL
authors.lastname: Zhong
authors.forename: Yu-Pin
authors.initials: YP
authors.lastname: Tan
mesh_terms: D000818:Animals; D001190:Arylsulfonates / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004804:Eosinophils / Q000187:drug effects; D015848:Interleukin-5 / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000235:genetics; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013452:Sulfonium Compounds / Q000627:therapeutic use*
chemical_list: D001190:Arylsulfonates; D015848:Interleukin-5; D013452:Sulfonium Compounds; C073028:suplatast tosilate